ICU sedation, delirium & recovery

Association between days alive without life support/out of hospital and health‐related quality of life

Acta Anaesthesiol ScandPublished Secondary analysis of the COVID STEROID 2 and Handling Oxygenation Targets in the Intensive Care Unit (HOT-ICU) randomised trials

Authors' conclusion

DAWOLS and DAOOH were poorly associated with HRQoL in adult survivors of severe or critical illness included in the COVID STEROID 2 and HOT-ICU trials.

Study context

Population
Adults with COVID-19 and severe hypoxaemia (COVID STEROID 2) and adult ICU patients with acute hypoxaemic respiratory failure (HOT-ICU)
Primary endpoint
Associations between DAWOLS and DAOOH and long-term HRQoL (EQ VAS and EQ-5D-5L index values)
Follow-up
DAWOLS/DAOOH at day 28 and 90; HRQoL after 6 or 12 months
Methodological detailsinternal performance and external validation
  • Internal performance and external validation

Primary result

As reported in the abstract

Association of DAWOLS/DAOOH with HRQoL in survivors
  • No strong associations between days alive without life support (DAWOLS) or days alive out of hospital (DAOOH) and health-related quality of life (HRQoL) in survivors at HRQoL follow-up (615 and 1476 patients, respectively)
  • Predictions from best fitted models poor internally and externally, with inadequate calibration

Further findings

Association including non-survivors

Moderate associations; predictions uncertain and calibration inadequate

Original publication

Association between days alive without life support/out of hospital and health‐related quality of life. Acta Anaesthesiol Scand. Published 21 March 2023. doi:10.1111/aas.14231

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.